I will purchase BSX soon. Your chart of BSX's medical device peers should give you hope. This company has put its problems behind it, for the most part, and the price should revert to the industry mean. They have enormous cash flow that is being directed at paying debt down and a large part of this year's sales will be from new products. The concern about the efficacy of drug eluding stents has passed, as has the concern of market share loss of the company's products. All of the subsidiaries are experiencing positive growth. The only concern on the horizon would be if Congress cut medicare subsidies and I have not heard anything about that occurring.
This company has been beat to a pulp for the past few years and with good reason, but don't give up now. Hopefully, and recent performance appears to indicate, their darkest hour is behind them and better days are here. Look at their performance today, so far, up on a terrible day. Good luck, all.
They only have a trickle of free cash flow, and all of that is directed towards paying lost patent infringement lawsuits, namely $800 million+ to JNJ and MDT. That cash flow also needs to be given to Jimmy as performance bonus. As for new products, Teligen has a set-screw issue which will require a re-design, Tobin even admitted this in the 2008 Q3 earnings call.
This Co. has not put Jimmy "the Nitwit" Tobin behind it. Hence, problems should not be discounted at any point or segment within the Co. Charts and event history will provide clear reference to the Harvard "genius" and his mgt "skills". GLTU. You will need it.